Litcius/Paper detail

Stereotactic body radiotherapy with or without selective dismutase mimetic in pancreatic adenocarcinoma: an adaptive, randomised, double-blind, placebo-controlled, phase 1b/2 trial

Cullen M. Taniguchi, Jessica M. Frakes, Todd A. Aguilera, Manisha Palta, Brian G. Czito, Manoop S. Bhutani, Lauren E. Colbert, Joseph Abi Jaoude, Vincent Bernard, Shubham Pant, Ching‐Wei D. Tzeng, Dae Won Kim, Mokenge P. Malafa, James Costello, Geena Mathew, Neal Rebueno, Eugene J. Koay, Prajnan Das, Ethan B. Ludmir, Matthew H. G. Katz, Robert A. Wolff, Sam Beddar, Gabriel O. Sawakuchi, Shalini Moningi, Rebecca S. Tidwell, Ying Yuan, Peter F. Thall, Robert A. Beardsley, Jon Holmlund, Joseph M. Herman, Sarah E. Hoffe

2023The Lancet Oncology33 citationsDOIOpen Access PDF

Topics & Concepts

PlaceboMedicineDouble blindPancreatic ductal adenocarcinomaPhase (matter)Internal medicineOncologyPancreatic cancerPathologyCancerChemistryAlternative medicineOrganic chemistryPancreatic and Hepatic Oncology ResearchCholangiocarcinoma and Gallbladder Cancer StudiesHepatocellular Carcinoma Treatment and Prognosis